Biomarcadores en enfermedad inflamatoria intestinal: ¿sabe cómo utilizarlos? / Biomarkers in inflammatory bowel disease
Rev. méd. Chile
;
148(3): 362-370, mar. 2020. graf
Artículo
en Español
| LILACS
| ID: biblio-1115800
ABSTRACT
Biomarkers in inflammatory bowel disease are an essential tool in clinical practice. They allow a non-invasive evaluation of patients and thus guide decision-making at different stages of the disease, including diagnostic suspicion, severity assessment, relapse prediction, and treatment response. Although biomarkers in blood such as erythrocyte sedimentation rate and C-reactive protein, are the most commonly used biomarkers, because their low cost and accessibility, they lack specificity. Currently, fecal biomarkers offer greater reliability, applicability, and specificity. Fecal calprotectin is the most commonly used marker. This review discusses the advantages and disadvantages of biomarkers in inflammatory bowel disease, as well as their clinical applications and new biomarkers currently under research.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Enfermedades Inflamatorias del Intestino
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Español
Revista:
Rev. méd. Chile
Asunto de la revista:
Medicina
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
Chile
Institución/País de afiliación:
Clínica Las Condes/CL
/
Hospital Clínico Universidad de Chile/CL
Similares
MEDLINE
...
LILACS
LIS